Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GIN...

por Elie, C, Geay, J F, Morcos, M, Le Tourneau, A, Girre, V, Broët, P, Marmey, B, Chauvenet, L, Audouin, J, Pujade-Lauraine, E, Camilleri-Broët, S
Publicado 2004

The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers

por Chakrabarti, J, Turley, H, Campo, L, Han, C, Harris, A L, Gatter, K C, Fox, S B
Publicado 2004

High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma

por Hiyama, E, Yamaoka, H, Matsunaga, T, Hayashi, Y, Ando, H, Suita, S, Horie, H, Kaneko, M, Sasaki, F, Hashizume, K, Nakagawara, A, Ohnuma, N, Yokoyama, T
Publicado 2004

Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort

por Peto, J, Gilham, C, Deacon, J, Taylor, C, Evans, C, Binns, W, Haywood, M, Elanko, N, Coleman, D, Yule, R, Desai, M
Publicado 2004

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

por Morris, S L, Low, S H, A'Hern, R P, Eisen, T G, Gore, M E, Nutting, C M, Harrington, K J
Publicado 2004

Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models

por Dev, I K, Dornsife, R E, Hopper, T M, Onori, J A, Miller, C G, Harrington, L E, Dold, K M, Mullin, R J, Johnson, J H, Crosby, R M, Truesdale, A T, Epperly, A H, Hinkle, K W, Cheung, M, Stafford, J A, Luttrell, D K, Kumar, R
Publicado 2004

Latent effects of fibronectin, α5β1 integrin, αVβ5 integrin and the cytoskeleton regulate pancreatic carcinoma cell IL-8 secretion

por Lowrie, A G, Salter, D M, Ross, J A
Publicado 2004

Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica

por Wang, S S, Schiffman, M, Herrero, R, Carreon, J, Hildesheim, A, Rodriguez, A C, Bratti, M C, Sherman, M E, Morales, J, Guillen, D, Alfaro, M, Clayman, B, Burk, R D, Viscidi, R P
Publicado 2004

Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice

por Jamerson, M H, Johnson, M D, Korsmeyer, S J, Furth, P A, Dickson, R B
Publicado 2004

Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with i...

por Chau, I, Norman, A R, Cunningham, D, Waters, J S, Topham, C, Middleton, G, Hill, M, Ross, P J, Katopodis, R, Stewart, G, Oates, J R
Publicado 2004

Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer

por Saunders, M P, Hogg, M, Carrington, B, Sjursen, A-M, Allen, J, Beech, J, Swindell, R, Valle, J W
Publicado 2004

Wild-type oestrogen receptor beta (ERβ1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers

por O'Neill, P A, Davies, M P A, Shaaban, A M, Innes, H, Torevell, A, Sibson, D R, Foster, C S
Publicado 2004

Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells

por Journe, F, Chaboteaux, C, Dumon, J-C, Leclercq, G, Laurent, G, Body, J-J
Publicado 2004

Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma

por Deplanque, G, Madhusudan, S, Jones, P H, Wellmann, S, Christodoulos, K, Talbot, D C, Ganesan, T S, Blann, A, Harris, A L
Publicado 2004

Living arrangements and place of death of older people with cancer in England and Wales: a record linkage study

por Grundy, E, Mayer, D, Young, H, Sloggett, A
Publicado 2004

Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours

por Harries, M, O'Donnell, A, Scurr, M, Reade, S, Cole, C, Judson, I, Greystoke, A, Twelves, C, Kaye, S
Publicado 2004

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study

por Bjørge, T, Lie, A K, Hovig, E, Gislefoss, R E, Hansen, S, Jellum, E, Langseth, H, Nustad, K, Tropé, C G, Dørum, A
Publicado 2004

A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours

por Contreras-Hernández, I, Mould-Quevedo, J F, Silva, A, Salinas-Escudero, G, Villasís-Keever, M A, Granados-García, V, Dávila-Loaiza, G, Petersen, J A, Garduño-Espinosa, J
Publicado 2008

SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response

por Cheetham, S, Tang, M J, Mesak, F, Kennecke, H, Owen, D, Tai, I T
Publicado 2008

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation

por van Roosmalen, M S, Stalmeier, P F M, Verhoef, L C G, Hoekstra-Weebers, J E H M, Oosterwijk, J C, Hoogerbrugge, N, Moog, U, van Daal, W A J
Publicado 2004